ES2134798T3 - Uso de analogos de somatostatina para el tratamiento de melanomas. - Google Patents

Uso de analogos de somatostatina para el tratamiento de melanomas.

Info

Publication number
ES2134798T3
ES2134798T3 ES92906420T ES92906420T ES2134798T3 ES 2134798 T3 ES2134798 T3 ES 2134798T3 ES 92906420 T ES92906420 T ES 92906420T ES 92906420 T ES92906420 T ES 92906420T ES 2134798 T3 ES2134798 T3 ES 2134798T3
Authority
ES
Spain
Prior art keywords
somatostatine
melanomas
analogs
treatment
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92906420T
Other languages
English (en)
Inventor
Arthur E Bogden
Jacques-Pierre Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Bioscience Inc
Original Assignee
Ipsen Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Bioscience Inc filed Critical Ipsen Bioscience Inc
Application granted granted Critical
Publication of ES2134798T3 publication Critical patent/ES2134798T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

UNA COMPOSICION PARA TRATAR UN MAMIFERO QUE SUFRE DE UNA ENFERMEDAD PROLIFERATIVA DE LA PIEL BENIGNA O MALIGNA, QUE COMPRENDE UNA CANTIDAD EFECTIVA DE UNA SOMATOSTATINA ANALOGA QUE CONTENGA SEIS O MAS AMINOACIDOS, FORMULADOS CON UN EXCIPIENTE ADECUADO PARA LA ADMINISTRACION TOPICA A DICHO MAMIFERO.
ES92906420T 1991-02-08 1992-02-07 Uso de analogos de somatostatina para el tratamiento de melanomas. Expired - Lifetime ES2134798T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65286391A 1991-02-08 1991-02-08

Publications (1)

Publication Number Publication Date
ES2134798T3 true ES2134798T3 (es) 1999-10-16

Family

ID=24618499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92906420T Expired - Lifetime ES2134798T3 (es) 1991-02-08 1992-02-07 Uso de analogos de somatostatina para el tratamiento de melanomas.

Country Status (12)

Country Link
US (1) US6087337A (es)
EP (1) EP0542934B1 (es)
JP (1) JPH05506254A (es)
AT (1) ATE181240T1 (es)
CA (1) CA2079896A1 (es)
DE (1) DE69229436T2 (es)
DK (1) DK0542934T3 (es)
ES (1) ES2134798T3 (es)
GR (1) GR3030856T3 (es)
IE (1) IE920416A1 (es)
PT (1) PT100111B (es)
WO (1) WO1992013554A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
EP3007704B1 (en) * 2013-06-13 2021-01-06 Antisense Therapeutics Ltd Combination therapy for acromegaly

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
CY1327A (en) * 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
DK375789A (da) * 1988-08-18 1990-02-19 Syntex Inc Peptidderivater
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
ATE140237T1 (de) * 1989-12-08 1996-07-15 Univ Tulane Oktapeptidanaloge von somatostatin mit threonin in position 6
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE69229436T2 (de) 1999-11-25
DE69229436D1 (de) 1999-07-22
DK0542934T3 (da) 1999-11-22
CA2079896A1 (en) 1992-08-09
EP0542934A4 (en) 1993-07-07
GR3030856T3 (en) 1999-11-30
EP0542934A1 (en) 1993-05-26
US6087337A (en) 2000-07-11
JPH05506254A (ja) 1993-09-16
ATE181240T1 (de) 1999-07-15
IE920416A1 (en) 1992-08-12
PT100111A (pt) 1993-06-30
EP0542934B1 (en) 1999-06-16
PT100111B (pt) 1999-06-30
WO1992013554A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BR9609503A (pt) Composto, uso de um composto, processo de tratamento de condições onde a inibição de pde especìfico para cgmp é de benefìcio terapêutico, em corpo de animal humano ou não humano, composição farmacêutica, e processos para preparar a mesma e um composto
DK0954299T3 (da) Thyroxin-analoger uden signifikant hormonal aktivitet til behandling af ondartede tumorer
BR9805544A (pt) Uso de um composto.
ES502656A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
ES509529A0 (es) "un procedimiento para la preparacion de derivados de tetrahidronaftaleno y de indano".
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
ES2134798T3 (es) Uso de analogos de somatostatina para el tratamiento de melanomas.
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES502654A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
SE9601396D0 (sv) New therapeutic treatment 2
EA200100140A1 (ru) Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами
DE69218200T2 (de) Behandlung von leberkrebs
DE69006931D1 (de) Ghilanten: antimetastatischer Wirkstoff aus dem südamerikanischen Blutegel Haementeria Ghilianii.
HUP9904578A2 (hu) Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
ATE74505T1 (de) Schmerzpraeparat.
EP1011672A4 (en) CONNECTIONS WITH ANALGETIC EFFECT AND COMPILATIONS THAT CONTAIN THEM
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 542934

Country of ref document: ES